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Abstract
Background: Shoulder pain is common in primary care, and has an unfavourable outcome in many
patients. Information on the costs associated with health care use and loss of productivity in
patients with shoulder pain is very scarce. The objective of this study was to determine shoulder
pain related costs during the 6 months after first consultation in general practice
Methods: A prospective cohort study consisting of 587 patients with a new episode of shoulder
pain was conducted with a follow-up period of 6 months. Data on costs were collected by means
of a cost diary during 6 months.
Results: 84% of the patients completed all cost diaries. The mean consumption of direct health
care and non-health related care was low. During 6 months after first consultation for shoulder
pain, the mean total costs a patient generated were €689. Almost 50% of this total concerned
indirect costs, caused by sick leave from paid work. A small proportion (12%) of the population
generated 74% of the total costs.
Conclusion: The total costs in the 6 months after first consultation for shoulder pain in primary
care, mostly generated by a small part of the population, are not alarmingly high.
Background
Shoulder pain is common with a one-year prevalence
ranging between 5% and 47%[1-6]. The prevalence in the
general population in The Netherlands has recently been
estimated at 17% [7]. The annual incidence of shoulder
pain in Dutch general practice ranges between 12 and 25/
1000/year [7-9]. Shoulder pain has an unfavourable out-
come in many patients. About 40 to 50% of all patients
who present with a new episode of shoulder pain in pri-
mary care report persistent symptoms after 6 to 12
months [10-12].
Musculoskeletal disorders are the second most expensive
disease group for health care costs in the Netherlands, and
represent 6% of the total healthcare costs [13]. Informa-
tion on the costs associated with health care use and loss
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of productivity in patients with shoulder pain is very
scarce, especially for the large majority of patients who are
treated in primary health care.
We performed a cohort study among patients who pre-
sented shoulder pain to their general practitioner, and fol-
lowed them for 6 months. Our objective was to determine
the shoulder pain related costs during the 6 months fol-




Between January 2001 and June 2003, 103 general practi-
tioners (GPs) recruited patients at first consultation for a
new episode of shoulder complaints in three geographic
areas in the Netherlands (Amsterdam, Groningen and
Maastricht).
In this study shoulder pain was defined according to the
1999 version of the Dutch guidelines for shoulder com-
plaints, issued by the Dutch College of General Practition-
ers [14,15]. Shoulder pain was characterized as pain in the
deltoid and upper arm region. Pain and stiffness were the
prominent complaints. Pain and stiffness restricted the
use of the arm and therefore limited daily activities, espe-
cially when using the hands above shoulder level. Lying
on the affected shoulder was painful, indicating that
severe shoulder pain could cause problems with sleeping.
Patients were selected if they were older than 18 years of
age, and had not consulted their GP or received any form
of treatment for the afflicted shoulder in the preceding
three months. Sufficient knowledge of the Dutch lan-
guage was required to complete written questionnaires.
Exclusion criteria were severe physical or psychological
conditions (i.e. fractures or luxation in the shoulder
region; rheumatic disease; neoplasm; neurological or vas-
cular disorders; dementia).
Management of shoulder pain
The participating GPs were educated and trained to apply
treatment according to the 1999 version of the Dutch
guidelines for shoulder disorders issued by the Dutch Col-
lege of General Practitioners[14,15]. The guidelines rec-
ommend giving information on the prognosis of shoulder
pain, advice regarding provoking activities, and stepwise
treatment consisting of paracetamol, Non-Steroidal Anti-
Inflammatory Drugs (NSAIDs), corticosteroid injection or
referral to physiotherapy. The participating GPs made the
decision regarding the content of treatment based on
duration and severity of pain and disability.
Costs
Cost data were collected from a societal perspective, using
a cost diary that has been shown to be valid and feasible
for patient completion [16]. The diary was presented in a
booklet form, containing instructions, an example of how
to complete the diary, and a telephone number in case of
questions. Patients were asked to complete five cost dia-
ries during the entire follow-up period of 26 weeks, which
was divided in five time periods: weeks 1–6, weeks 7–12,
weeks 13–18, weeks 19–22, and weeks 23–26. Patients
received a new diary by post at the beginning of a period
and a return envelop for the previous diary. Patients were
reminded by post after two weeks or telephoned after
three weeks if they had not returned the previous diary.
The cost diary included direct health care costs relevant to
the treatment of shoulder complaints, such as visits to a
general practitioner, physiotherapist, manual therapist,
occupational therapist, 'Mensendieck' or 'Cesar' exercise
therapist or complementary health therapists (e.g. acu-
puncturist), visits to a consultant in orthopedic surgery,
neurology, rheumatology, or rehabilitation medicine, and
hospitalization. Direct non-health care costs included out
of pocket expenses, costs of performing extra activities
(i.e. swimming, fitness, gymnastics), homecare and costs
for paid and unpaid help. Indirect costs included costs of
loss of production due to shoulder complaints, which was
measured by sick leave from paid and unpaid work, and
inability to perform usual activities and hobbies. Indirect
costs for paid work were calculated using the friction cost
method[17,18]. This method takes into account that sick
workers can be replaced after a certain period of time, i.e.
the friction period, depending on the elasticity of the
labour market. In the Netherlands the friction period has
been estimated at 123 days. Friction costs were based on
the mean income of the Dutch population per gender and
5-year age group[17,18]. We used a shadow price for
unpaid work of €8.60 per hour [17,18]. A complete over-
view of the unit costs we used is given in Table 1. Medica-
tion costs were based on the prices provided by the Royal
Dutch Society for Pharmacy [19].
Data analysis
We compared the baseline characteristics of patients who
completed all cost diaries with those who did not and
analysed possible differences using multiple logistic
regression analysis. Health care consumption for shoulder
pain and associated costs are presented in tables, for three
time periods separately: short-term (1–6 weeks), interme-
diate term (7–12 weeks), and long-term follow-up (13–
26 weeks). The arithmetic mean, standard deviations,
maximum value (only for consumption) were computed
for direct (health and non-health related care), and indi-
rect costs. Despite the skewness in the distribution of
costs, it is the arithmetic mean that is the most informa-
tive measure for health care policy makers [20,21]. Meas-BMC Musculoskeletal Disorders 2006, 7:83 http://www.biomedcentral.com/1471-2474/7/83
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ures other than the arithmetic mean provide no
information about the total cost of treating all patients.
We also described the costs separately for patients with
persistent symptoms after 6 months and for those report-
ing recovery. This 'Patient perceived recovery' was meas-
ured on an 8-point rating scale (very much detoriation,
much detoriation, some detoriation, no change, some
improvement, much improvement, very much improve-
ment, fully recovered). Patients who did not report full
recovery or very much improvement were denoted as hav-
ing "persistent symptoms" The cut-off point was deter-
mined a priori, based on previous research by the project
team [22,23].
The study was approved by the Medical Ethics Committee




A total of 587 patients were included in the cohort study.
A total of 95 patients did not return one or more of their
cost diaries. A multiple logistic regression analysis showed
that patients with incomplete cost data were significantly
(p < 0.10) younger (46 years versus 52 years) and had
more concomitant neck pain (38% versus 35%). The
results of this study were based on the 492 patients (84%)
who completed all five cost diaries. Table 2 presents their
baseline characteristics.
Health care consumption and sick leave
Health care consumption and sick leave are presented in
Table 3. The mean number of visits to GPs), specialists,
allied health professionals, and complementary health
therapists was low, as well as the mean consumption of
non-health related care (home care, paid and unpaid
help, extra activities). Productivity losses were not consid-
ered high as well, with a mean number of days sick leave
from paid work of 2.8 days (sd ± 13) over a period of 6
months. Table 3 shows that most estimations have large
standard deviations.
Costs
The mean costs and standard deviations are presented in
Table 4. During the 6 months after first consultation for
shoulder pain, the mean total costs a patient generated
were €689 (sd ± 1965). A large proportion (47%) of the
total costs was due to indirect costs of productivity losses.
Mean total costs due to sick leave from paid work in
patients with a paid job were €523 (sd ± 2054). Treatment
by a therapist (mostly physiotherapists, Table 3)
accounted for 37% of the total direct costs. One patient
underwent surgery for his shoulder complaints, and gen-
erated €2715, which reflects 1 day of hospitalization and
the costs of a neck operation. The costs generated in the
first six weeks (€276 ± 758) were almost equal to the costs
generated in the final three months of the follow-up
period (€257 ± 962). So, the highest costs per week were
generated in the first 6 weeks after consultation. Table 5
Table 1: Cost used in the economic evaluation
Costs €
Direct health care costs (per visit)
General practitioner (max 10 min) 18.97
Manual therapist (max 20 min) 19.65
Other therapists (max 30 min) (physiotherapist, 'Mensendieck', 'Cesar' and occupational therapist) 19.65
Specialists (orthopaedist, neurologist, rheumatologist, and physician for rehabilitation medicine) 44.21
Hospitalisation (per day) 337.00
Direct non-health care costs (per hour)
Alternative therapists (acupuncturist, homeopath, chiropractor, and others) As indicated by patient
Home care 8.60
Paid help at home 8.60
Help from partner/relatives/friends 8.60
Extra activities (i.e. swimming, fitness, gymnastics) 8.60
Indirect costs (per hour)
Sick leave from paid work FCM
Sick leave from unpaid work 8.60
Unable to perform usual activities 8.60
Unable to perform hobbies 8.60
€: Euro's (€1 = 1.30 US Dollars, 02/02/2005); FCM: friction cost methodBMC Musculoskeletal Disorders 2006, 7:83 http://www.biomedcentral.com/1471-2474/7/83
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shows that patients reporting persistent symptoms gener-
ated more than twice as much costs compared with
patients reporting recovery after 6 months.
Figure 1 describes the distribution of the total costs in the
population. A small proportion of the population (n = 61;
12%) generated more than €1000 per patient during 6
months after first consultation. This skewness was illus-
trated by the fact that median total direct costs were only
€105 (Inter Quartile Range 19–317) and the median total
indirect costs €0 (IQR 0–75). These 61 patients (12%)
were responsible for 74% of the total costs. These small
subset of the population differed considerably (>10%) at
baseline from the total study population, reporting more
sick leave at baseline in the preceding 2 months, more
often strain due to usual activities as precipitating cause,
more shoulder or neck complaints in the past, more con-
comitant neck, high back, or back pain, higher intensity of
shoulder pain, more shoulder disability, and more shoul-
der and neck pain at physical examination (Table 2). The
prevalence of persistent symptoms after 6 months in this
subgroup was 70%. Sick leave from paid work in 6
months after consultation accounted for 61% of the total
costs in this subgroup.
Discussion
The present study is the first to evaluate the overall costs
generated by patients presenting with shoulder pain in
Table 2: Baseline characteristics of patients with shoulder pain
Variable n = 492 n = 61*
Demographic
Age (years); mean (SD) 52 (14) 50 (14)
Gender: male; n (%) 245 (50) 25 (41)
Paid work; n (%) 350 (60) 38 (62)
Disease characteristics
Duration of current shoulder complaints; n (%)
0–6 weeks 179 (37) 18 (30)
7–12 weeks 117 (24) 15 (25)
>12 weeks 195 (40) 28 (46)
Sick leave at baseline in preceding 2 months$; n (%)
0 weeks 254 (74) 21 (57)
≤1 weeks 44 (13) 5 (13)
>1 weeks 46 (13) 11 (30)
Gradual onset; n (%) 310 (63) 36 (59)
Precipitating cause; n (%)
Strain/overuse: usual activities; n (%) 115 (23) 22 (36)
Shoulder complaints in the past; n (%) 291 (59) 42 (69)
Neck complaints in the past; n (%) 251 (51) 41 (68)
Dominant side involved; n (%) 302 (61) 42 (69)
Comorbid psychological complaints; n (%) 42 (9) 9 (15)
Concomitant musculoskeletal complaints; n (%)
Neck/high back 173 (35) 35 (57)
Low back pain 117 (24) 24 (39)
Upper extremity 152 (31) 21 (34)
Shoulder pain (0–10); mean (SD) 4.7 (2.3) 6.2 (1.9)
Shoulder disability (0–100); mean (SD) 60.0 (23.8) 72.0 (20.2)
Physical examination
Pain shoulder with movement (0–18); median (IQR) 6 (4–6) 8 (6–8)
Pain neck with movement (0–18); median (IQR) 0 (0-0) 3 (0–2)
Physical factors
Dynamic physical workload (0–5); median (IQR) 1 (0–1) 1 (1-1)
Repetitive movements; n (%) 316 (64) 43 (71)
*Subgroup of patients generating costs of >€1000 in 6 months. SD = standard deviation; IQR = Inter quartile range
$ Sick leave due to shoulder painBMC Musculoskeletal Disorders 2006, 7:83 http://www.biomedcentral.com/1471-2474/7/83
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primary care. Healthcare consumption and sick leave did
not seem to be alarmingly high in this primary care pop-
ulation with mean total costs of €689 per patient during
the 6 months after first consultation. A small part (12%)
of the population accounted for 74% of the total costs.
The response rate was high (84%) and differences at base-
line between completers (all 5 five cost diaries) and non-
completers (<5 cost diaries) were small. We expect that
the differences in age and concomitant neck pain between
completers and non-completers will not have substan-
tially influenced our cost estimates.
There was a high percentage of patients who reported per-
sistent symptoms after 6 weeks (70%) and 6 months
(46%) in this population [24]. These rates are similar to
those found in other studies carried out in primary care
populations [10-12], which may strengthen the generalis-
ability of our findings to other primary care patients with
shoulder disorders. There was little health care consump-
tion and shoulder pain related sick leave in this study. As
a consequence shoulder pain related costs per patient
were low. Only one patient reported 130 days of sick leave
in the 6 months after consultation, which was more than
the friction period of 123 days.
An explanation for the modest health care costs could be
that general practitioners stick to the interventions recom-
mended in the Dutch guidelines for shoulder disorders
[14,15] (wait-and-see policy with pain medication, fol-
lowed by injections), which are relatively inexpensive.
Possibly, the fact that GPs were instructed to follow the
guideline could have influenced the generalisability of
our results because GPs who did not participate in our
study subscribe other interventions, which could have
resulted results in different costs estimates. The guideline,
however, is not complicated and in line with daily practice
(stepwise management regime). The guideline was issued
in 1999, a few years before the inclusion of our study
started. So, GPs who did not participate in the study could
have been influenced by the guideline as much as GPs
who participated in the study and followed a course dur-
ing a half day. So, we do not expect this to strongly influ-
ence the generalisability of our findings.
The costs of physiotherapy represented a relatively large
proportion of the direct health care costs, but accounted
for only 14% of the total costs, as few patients were
referred for therapy (Table 4). Indirect costs accounted for
a large proportion (47%) of the total costs. Nevertheless,
the total number of days sick leave per patients was small
Table 3: Consumption of healthcare resources and sick leave from work during 26 weeks after first consultation for shoulder 
complaints (n = 492)
week 1–6 week 7–12 week 13–26 Total (week 1–26)
Direct health care
General practitioner [no. of visits] 1.6 ± 0.9 (6) 0.2 ± 0.6 (4) 0.3 ± 0.7 (5) 2.1 ± 1.5 (9)
Allied health professionals [no. of visits]
Physiotherapist 1.5 ± 3.0 (13) 1.1 ± 2.6 (16) 1.5 ± 4.1 (28) 4.1 ± 7.6 (45)
Manual therapist 0.2 ± 1.0 (11) 0.2 ± 0.9 (9) 0.2 ± 1.1 (11) 0.5 ± 2.2 (20)
Other therapists 0.1 ± 0.5 (6) 0.0 ± 0.3 (4) 0.1 ± 0.7 (12) 0.2 ± 1.2 (19)
Specialists [no. of visits] 0.0 ± 0.3 (3) 0.0 ± 0.2 (2) 0.1 ± 0.5 (5) 0.2 ± 0.8 (7)
Hospitalisation [days] - - 0.0 ± 0.0 (1) 0.0 ± 0.0 (1)
Direct non-health care
Alternative therapists [no. of visits] 0.1 ± 0.5 (6) 0.1 ± 0.5 (8) 0.2 ± 0.9 (11) 0.3 ± 1.6 (17)
Home care [hours] 0.1 ± 1.2 (22) 0.0 ± 0.8 (15) 0.2 ± 2.0 (32) 0.3 ± 3.1 (51)
Paid help [hours] 0.4 ± 3.6 (48) 0.5 ± 4.3 (60) 0.7 ± 5.7 (80) 1.7 ± 12.4 (176)
Help from partner/relatives/friends [hours] 1.1 ± 8.7 (152) 0.9 ± 8.9 (168) 1.0 ± 6.3 (72) 3.2 ± 16.1 (212)
Extra activities [hours] 0.8 ± 3.9 (44) 1.0 ± 5.3 (93) 1.4 ± 6.9 (95) 3.2 ± 11.6 (121)
Indirect
Sick leave from paid work [days] 1.1 ± 5.0 (42) 0.6 ± 3.6 (30) 1.1 ± 6.3 (63) 2.8 ± 13.0 (123)
Sick leave from unpaid work [days] 1.9 ± 9.6 (120) 1.4 ± 9.9 (168) 1.6 ± 9.5 (104) 4.9 ± 24.2 (322)
Unable to perform usual activities [hours] 1.4 ± 7.7 (106) 0.9 ± 6.7 (108) 1.0 ± 7.3 (104) 3.2 ± 16.1 (212)
Unable to perform hobbies [hours] 2.8 ± 9.9 (120) 1.1 ± 5.7 (84) 1.3 ± 6.8 (75) 5.3 ± 16.3 (139)
Presented are group means, standard deviations and the maximum value between brackets.
Other therapists: Mensendieck, Cesar, occupational therapists, or other.
Specialists: orthopaedist; neurologist; rheumatologist; physician for rehabilitation medicine, or other.
Alternative therapists: acupuncturist; homeopath; chiropractor; hypnotist; magnetism therapist, or other.BMC Musculoskeletal Disorders 2006, 7:83 http://www.biomedcentral.com/1471-2474/7/83
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(2.8 days) over a period of 6 months. Possibly, factors
such as shoulder pain, sleeping problems, or loss of func-
tion have caused loss of productivity in patients without
sick leave from paid work. Our study does not provide
information on the actual loss of productivity among
those who kept on working regardless of the shoulder
pain ("work presenteeism"), or costs related to hiring and
training replacements, spill-over effects to co-workers,
and compensatory mechanisms that may reduce or
increase the overall productivity loss [25]. Clearly, a more
adequate estimation of production loss is needed to
improve the meaningfulness of future studies.
Similar to studies on low back pain [26], in this study a
small proportion of the population (n = 61; 12%) caused
a substantial part (74%) of the total costs. In this sub-
group sick leave from paid work accounted for 61% of the
total costs. In a prognostic study we found the following
factors predicting sick leave from paid work in 6 months
after consultation: sick leave in the preceding 2 months,
shoulder pain, precipitating cause: strain due to usual
activities and concomitant psychological complaints[27].
Table 2 shows that the subgroup who generated most
costs, not surprisingly, also showed higher scores on these
variables compared to the total population (Table 2).
Table 2 also shows substantial differences between the
groups regarding shoulder or neck pain at physical exam-
ination, and concomitant back pain at baseline. This
seems plausible as these factors were shown to be of pre-
dictive value for persistent shoulder pain after 6 weeks and
6 months in our cohort [24].
In this study we were able to include a follow-up of 26
weeks. It is possible that prolonged and recurrent pain
episodes generate additional costs for more expensive
care, e.g. diagnostic imaging and surgical treatment,
including hospitalization. Given the poor prognosis of
shoulder pain (approximately 40% of patients report per-
sistent symptoms after 12 to 18 months [10-12]. higher
health care costs and productivity losses may be expected
when follow-up times are longer. In the 6 months follow-
ing first consultation, few costs were made due to referrals
to other health care providers, additional diagnostic pro-
cedures, or surgery. We expect these kinds of health care
expenses to occur in the long-term in a small subset of the
population. In our inception cohort patients with frac-
Table 4: Mean costs (€) made in 26 weeks after first consultation for shoulder complaints (n = 492)
week 1–6 week 7–12 week 13–26 Total (week 1–26)
Direct health care costs 69 ± 66 32 ± 57 52 ± 179 152 ± 232
General Practitioner 31 ± 17 4 ± 54 5 ± 14 40 ± 29
Allied health professionals 34 ± 62 25 ± 53 34 ± 87 93 ± 158
Specialists 2 ± 12 1 ± 9 5 ± 26 8 ± 36
Prescribed medication 2 ± 6 1 ± 3 1 ± 4 4 ± 10
Hospitalisation - - 6 ± 138 6 ± 138
Direct non-health care costs 30 ± 102 26 ± 108 41 ± 146 98 ± 293
Alternative therapists 5 ± 33 3 ± 28 8 ± 55 16 ± 94
Over-the-counter medication 2 ± 9 1 ± 9 4 ± 51 7 ± 58
Out-of-pocket expenses 2 ± 16 1 ± 8 1 ± 6 4 ± 21
Home care 1 ± 10 0.4 ± 7 2 ± 17 3 ± 27
Paid help 4 ± 31 5 ± 37 6 ± 49 15 ± 107
Help from partner/relatives/friends 10 ± 75 7 ± 76 8 ± 54 25 ± 168
Extra activities 7 ± 34 8 ± 45 12 ± 59 28 ± 100
Total direct costs 99 ± 130 58 ± 134 93 ± 244 250 ± 408
Indirect costs
Sick leave from paid work 125 ± 654 69 ± 461 130 ± 790 324 ± 1635
Sick leave from unpaid work 16 ± 83 12 ± 85 13 ± 82 42 ± 208
Unable to perform usual activities 12 ± 66 7 ± 57 9 ± 63 28 ± 139
Unable to perform hobbies 24 ± 85 10 ± 49 12 ± 59 46 ± 140
Total indirect costs 177 ± 711 99 ± 505 164 ± 829 439 ± 1751
Total costs 276 ± 758 156 ± 564 257 ± 962 689 ± 1965
Presented are group means, and standard deviations.BMC Musculoskeletal Disorders 2006, 7:83 http://www.biomedcentral.com/1471-2474/7/83
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tures, dislocation, or previous surgery were not included.
These patients are not included in this study, but may gen-
erate substantial costs in current practice.
Information on the costs associated with health care use
and loss of productivity in patients with shoulder pain is
very scarce, and therefore a comparison with other studies
is difficult. In the framework of this cohort study a ran-
domised controlled trial on the effectiveness of manipula-
tive therapy has been carried out [23]. This trial was
similar regarding outcome assessments and length of fol-
low-up. The control group of this trial (n = 71), who also
received usual care according to the Dutch general practice
guidelines, generated slightly lower costs (mean total
costs €555) compared to our cohort.
In conclusion, the total costs in the 26 weeks after first
consultation for shoulder pain, mostly generated by a
small part of the population, are not alarming. However,
after 26 weeks 46% of the patients still reported persistent
symptoms. More extensive research with a longer follow-
up to monitor these patients is needed, as they possibly
generate substantial costs. Given the high incidence of
shoulder pain (12/1000/year) [7-9] in general practice the
total costs to society could be higher than presented in
this study. It may be important to also include patients
with fractures, dislocation, or previous surgery to estimate
the total costs of illness for patients consulting with shoul-
der pain in primary care.
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